Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.

Author: AkgozSemra, BalkanEmin, DogruyolHasan, KilicNizamettin, SenNuri

Paper Details 
Original Abstract of the Article :
BACKGROUND: Treatment with anticholinergic agents is the mainstay of therapy for detrusor instability (DI), a chronic and morbid condition characterized by urge urinary incontinence. The aim of this study is to assess the effectiveness and tolerability of tolterodine and oxybutynin in children with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1442-2042.2006.01240.x

データ提供:米国国立医学図書館(NLM)

Tolterodine vs. Oxybutynin for Detrusor Instability in Children

The field of pediatric urology is focused on addressing the unique urinary challenges faced by children. This study compares the effectiveness and side-effect profiles of tolterodine and oxybutynin, two commonly used anticholinergic medications, in treating detrusor instability (DI) in children. It aims to provide clinicians with valuable insights for choosing the most appropriate treatment option based on tolerability and efficacy. This research is like a skilled camel caravan traversing the diverse terrain of pediatric urology, seeking to find the best path for treating DI in children.

Tolterodine Offers Better Tolerability for Children with DI

This study reveals that tolterodine is a viable treatment option for children with DI, demonstrating similar efficacy to oxybutynin with significantly fewer side effects. This finding suggests that tolterodine may offer a more tolerable alternative for long-term treatment, potentially enhancing patient compliance. This discovery is like finding a cooler and more refreshing oasis in the desert, offering a more comfortable and sustainable solution for managing DI in children.

Choosing the Right Treatment for Children with DI

This research provides clinicians with valuable insights for choosing the best treatment for children with DI. It highlights the potential of tolterodine as a well-tolerated and effective alternative to oxybutynin, particularly for long-term management. This research is like a compass guiding us through the complex desert of pediatric urinary disorders, offering a roadmap for choosing the best treatment path for children with DI.

Dr. Camel's Conclusion

This research is like a compassionate camel caravan seeking to provide the best possible care for children with DI. It offers a valuable comparison of treatment options, empowering clinicians to make informed decisions that prioritize both effectiveness and patient comfort.

Date :
  1. Date Completed 2006-08-30
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16563131

DOI: Digital Object Identifier

10.1111/j.1442-2042.2006.01240.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.